UBS Group cut shares of CareMax (NASDAQ:CMAX – Free Report) from a buy rating to a neutral rating in a report released on Friday, Marketbeat reports. The firm currently has $1.00 price objective on the stock, down from their previous price objective of $5.00.
Separately, Piper Sandler cut CareMax from an overweight rating to a neutral rating and lowered their target price for the stock from $3.00 to $2.00 in a report on Friday, November 10th.
CareMax Price Performance
Hedge Funds Weigh In On CareMax
Hedge funds have recently modified their holdings of the stock. Eminence Capital LP lifted its stake in CareMax by 11.3% in the 3rd quarter. Eminence Capital LP now owns 9,885,113 shares of the company’s stock valued at $20,956,000 after purchasing an additional 1,005,027 shares during the last quarter. BlackRock Inc. increased its stake in CareMax by 22.6% in the second quarter. BlackRock Inc. now owns 4,863,695 shares of the company’s stock valued at $15,126,000 after acquiring an additional 897,431 shares during the last quarter. Perceptive Advisors LLC increased its stake in CareMax by 6.7% in the second quarter. Perceptive Advisors LLC now owns 3,817,404 shares of the company’s stock valued at $11,872,000 after acquiring an additional 241,364 shares during the last quarter. Vanguard Group Inc. increased its stake in CareMax by 3.9% in the third quarter. Vanguard Group Inc. now owns 3,196,533 shares of the company’s stock valued at $22,663,000 after acquiring an additional 118,909 shares during the last quarter. Finally, Millennium Management LLC grew its stake in shares of CareMax by 3.2% during the second quarter. Millennium Management LLC now owns 2,513,711 shares of the company’s stock worth $9,125,000 after buying an additional 77,015 shares during the last quarter. Institutional investors own 65.94% of the company’s stock.
CareMax, Inc provides chronic disease management services through physicians and health care professionals. It offers a suite of health care and social services to its patients, including primary care, specialty care, telemedicine, health and wellness, optometry, dental, pharmacy, and transportation; and services to children and adults through Medicaid programs, as well as through commercial insurance plans.
- Five stocks we like better than CareMax
- Stock Dividend Cuts Happen Are You Ready?
- The most upgraded stocks in November have two things in common
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Monday.com rocked earnings like it’s the weekend
- How to Invest in E-Commerce: A Guide
- Plan to own one retailer? Make it this one
Receive News & Ratings for CareMax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CareMax and related companies with MarketBeat.com's FREE daily email newsletter.